PLIANT THERAPEUTICS, INC. — Form D/A
PLIANT THERAPEUTICS, INC. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2020-03-11. The offering totals $100.4M, of which $100.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-11
- Form: D/A
- Accession: 0001746473-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.4M
- Amount sold: $100.4M
- Investors: 66
- Date of first sale: 2019-12-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-357505
Issuer
- Name: PLIANT THERAPEUTICS, INC.
- CIK: 0001746473
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-481-6770
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Suzanne Bruhn | Director | CAMBRIDGE, MA |
| Bernard Coulie | Director | South San Francisco, CA |
| Gayle Crowell | Director | South San Francisco, CA |
| John Curnutte | Director | South San Francisco, CA |
| Neil Exter | Director | Boston, MA |
| Charles Homcy | Director | San Francisco, CA |
| Hoyoung Huh | Director | TAMPA, FL |
| Kevin Raidy | Director | Thousand Oaks, CA |
| Smital Shah | Director | South San Francisco, CA |
| Bernard Coulie | Executive Officer | South San Francisco, CA |
| Keith Cummings | Executive Officer | South San Francisco, CA |
| Barbara Howes | Executive Officer | South San Francisco, CA |
| Johannes Hull | Executive Officer | South San Francisco, CA |
| Eric Lefebvre | Executive Officer | South San Francisco, CA |
Other filings by this issuer (3)
More